Experience

Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Industrias Peñoles, S.A.B. de C.V. of $600 million aggregate principal amount of…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Textron Inc. of $500 million aggregate principal amount of its 2.450…

Davis Polk advised the joint book-running managers on an SEC-registered debt offering by Alphabet Inc., consisting of $1 billion of 0.450% notes due 2025, $1 billion of 0.800% notes…

Davis Polk advised the representative of the several underwriters in connection with the initial public offering of 82,800,00 units of CC Neuberger Principal Holdings II, including 10,800…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Clear Channel International B.V. (“CCI”), a wholly owned subsidiary of Clear Channel…

Davis Polk advised Graham Packaging Company Inc. on a Rule 144A/Regulation S offering of $510 million aggregate principal amount of its 7.125% senior notes due 2028. The notes are…

Davis Polk advised Vasta Platform Limited in connection with its SEC-registered initial public offering of an aggregate of 18,575,492 Class A common shares, at a price per Class A common…

Davis Polk advised the joint bookrunners in connection with the initial public offering by Grupo de Moda SOMA S.A. and the selling shareholders of 163,636,363 common shares for an…

Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…

Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…